1. Home
  2. CNTN vs AIRS Comparison

CNTN vs AIRS Comparison

Compare CNTN & AIRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Canton Strategic Holdings Inc. Common Stock

CNTN

Canton Strategic Holdings Inc. Common Stock

HOLD

Current Price

$1.88

Market Cap

178.5M

Sector

Health Care

ML Signal

HOLD

Logo AirSculpt Technologies Inc.

AIRS

AirSculpt Technologies Inc.

BUY

Current Price

$1.24

Market Cap

182.4M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
CNTN
AIRS
Founded
2017
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Nursing Services
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
178.5M
182.4M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
CNTN
AIRS
Price
$1.88
$1.24
Analyst Decision
Hold
Analyst Count
0
3
Target Price
N/A
★ $4.50
AVG Volume (30 Days)
730.9K
★ 826.2K
Earning Date
11-11-2026
11-06-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 88.10
N/A
EPS
N/A
★ N/A
Revenue
N/A
★ $151,818,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$2.65
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$1.66
$1.16
52 Week High
$5.27
$12.00

Technical Indicators

Market Signals
Indicator
CNTN
AIRS
Relative Strength Index (RSI) 43.05 24.50
Support Level $1.75 N/A
Resistance Level $2.40 $3.31
Average True Range (ATR) 0.15 0.13
MACD -0.03 -0.00
Stochastic Oscillator 30.24 8.57

Price Performance

Historical Comparison
CNTN
AIRS

About CNTN Canton Strategic Holdings Inc. Common Stock

Canton Strategic Holdings Inc is engaged in activities related to Canton Network, including the use of Canton Coin, to support blockchain-based infrastructure and the digitization of financial market processes. The company operates in two reportable segments: digital asset treasury and clinical stage bio-technology. Its flagship clinical asset, GV104, is being developed for a specific indication for respiratory and/or nervous system depression in military personnel and chemical incident responders. The expanded pipeline includes other indications for GV104 and GV023, an approach to autoimmune diseases as well as an early-stage multispecific biologic platform.

About AIRS AirSculpt Technologies Inc.

AirSculpt Technologies Inc is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results. Its proprietary and patented AirSculpt method is minimally invasive because it requires no needle, no scalpel, no stitches, and no general anesthesia. It offers fat removal procedures across treatment areas and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips or other areas and do not require silicone or foreign materials to be implanted. Its segment is direct medical procedure services.

Share on Social Networks: